|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.330
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.290
|
Mouse |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.266
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.250
|
Mouse |
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.175
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.158
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.154
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.144
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.144
|
Mouse |
|
|
regulation of system process
|
GO:0044057 |
200 |
0.139
|
Mouse |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.136
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.133
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.129
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.128
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.125
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.122
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.122
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.121
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.118
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.114
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.114
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.109
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.107
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.104
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.101
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.100
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.092
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.088
|
Human |
|
|
camera type eye development
|
GO:0043010 |
266 |
0.087
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.086
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.084
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.081
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.078
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.077
|
Mouse |
|
|
hair follicle development
|
GO:0001942 |
85 |
0.076
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.076
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.076
|
Mouse |
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.073
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.072
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.071
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.071
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.068
|
Mouse |
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.068
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.067
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.066
|
Mouse |
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.065
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.065
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.064
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.064
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.064
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.063
|
Mouse |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.063
|
Human |
|
|
wound healing
|
GO:0042060 |
157 |
0.063
|
Mouse |
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.062
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.062
|
Mouse |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.061
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.061
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.060
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.059
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.058
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.058
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.058
|
Mouse |
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.058
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.058
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.057
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.057
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.057
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.056
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.055
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.055
|
Mouse |
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.054
|
Mouse |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.054
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.053
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.053
|
Human |
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.053
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.051
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.051
|
Mouse |
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.051
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.051
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.051
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.050
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.050
|
Mouse |
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.049
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.048
|
Mouse |
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.048
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.047
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.047
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.047
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.047
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.046
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.046
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.046
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.046
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.045
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.045
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.045
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.044
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.043
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.043
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.043
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.043
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.043
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.043
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.043
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.042
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.042
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.042
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.041
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.041
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.041
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.041
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.041
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.041
|
Human |
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.040
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.040
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.040
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.040
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.040
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.040
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.040
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.039
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.039
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.039
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.039
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.039
|
Mouse |
|
|
diacylglycerol biosynthetic process
|
GO:0006651 |
2 |
0.039
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.038
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.038
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.038
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.038
|
Human |
|
|
learning or memory
|
GO:0007611 |
148 |
0.038
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.037
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.037
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.037
|
Mouse |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
Human |
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.036
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.036
|
Human |
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.036
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.036
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.036
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.036
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.036
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.036
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.036
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.035
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.035
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.035
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.035
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.035
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.035
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.035
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.035
|
Human |
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.035
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.035
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.035
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.035
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.034
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.034
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.033
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.033
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.033
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.033
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.032
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.032
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.032
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.032
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.032
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.032
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.032
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.031
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.031
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.031
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.031
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.031
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.031
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.030
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.030
|
Mouse |
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.030
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.030
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.030
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.030
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.029
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.029
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.029
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.029
|
Mouse |
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.029
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.029
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.029
|
Human |
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.029
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.029
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.029
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.029
|
Mouse |
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.029
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.028
|
Mouse |
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.028
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.028
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.028
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.028
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.028
|
Mouse |
|
|
blood circulation
|
GO:0008015 |
195 |
0.028
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.028
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.028
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.028
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.028
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.027
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.027
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.027
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.027
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.027
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.027
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.027
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.027
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.026
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.026
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.026
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.026
|
Human |
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.026
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.026
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.026
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.026
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.026
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.025
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.025
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.025
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.025
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.025
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.025
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.025
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.025
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.025
|
|
|
|
prostaglandin metabolic process
|
GO:0006693 |
11 |
0.025
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.025
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.024
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.024
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.024
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.024
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.024
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.024
|
Mouse |
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.024
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.024
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.024
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.024
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.024
|
|
|
|
sodium ion export from cell
|
GO:0036376 |
1 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.023
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.023
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.023
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.023
|
Mouse |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.023
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.023
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.022
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.022
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.022
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.022
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.022
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.022
|
Mouse |
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.022
|
Mouse |
|
|
amide transport
|
GO:0042886 |
138 |
0.022
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.022
|
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
3 |
0.022
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.022
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.022
|
Human |
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.022
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.022
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.022
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.022
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.022
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.021
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.021
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
Mouse |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.021
|
|
|
|
sodium ion export
|
GO:0071436 |
2 |
0.021
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.021
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.021
|
Mouse |
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.021
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.021
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.021
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.021
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.021
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.021
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.021
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.021
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.021
|
Mouse |
|
|
chemotaxis
|
GO:0006935 |
247 |
0.021
|
|
|
|
hypotonic response
|
GO:0006971 |
3 |
0.020
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.020
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.020
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.020
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.020
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.020
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.019
|
Mouse |
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.019
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.019
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.019
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.019
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.019
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
Mouse |
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.019
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.019
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.019
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.019
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.019
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.019
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.019
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.019
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.019
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.019
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.019
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.019
|
Mouse |
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.019
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.019
|
Mouse |
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.018
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.018
|
Human |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.018
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
Human |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.018
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.018
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.018
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.018
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.018
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.018
|
Mouse |
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.018
|
Mouse |
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.018
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.018
|
|
|
|
learning
|
GO:0007612 |
98 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.018
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.018
|
|
|
|
fatty acid derivative biosynthetic process
|
GO:1901570 |
15 |
0.018
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.017
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.017
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.017
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.017
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.017
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.017
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.017
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.017
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.017
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.017
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.017
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.017
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
Mouse |
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.017
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.017
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.017
|
Human |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.017
|
Mouse |
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.017
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.017
|
Mouse |
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.017
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.017
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.017
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.017
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.017
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.017
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.017
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.017
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.017
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.017
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.017
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.017
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.017
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.016
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.016
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.016
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.016
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.016
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.016
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.016
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.016
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.016
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.016
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.016
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
Mouse |
|
|
epinephrine transport
|
GO:0048241 |
1 |
0.016
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.016
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.016
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
Mouse |
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.016
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.016
|
Mouse |
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.016
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.016
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.016
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.016
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.016
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.016
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.016
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.015
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.015
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.015
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.015
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.015
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.015
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.015
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.015
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.015
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.015
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.015
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.015
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.015
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.015
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.015
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.015
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.015
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.015
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.015
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.015
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.015
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.015
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.015
|
|
|
|
epinephrine secretion
|
GO:0048242 |
1 |
0.015
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.014
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.014
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.014
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.014
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.014
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
negative regulation of bone trabecula formation
|
GO:1900155 |
1 |
0.014
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.014
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.014
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.014
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
Human |
|
|
lung development
|
GO:0030324 |
164 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.014
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.014
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.014
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.014
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.014
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.014
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.014
|
|
